作者
Yumiko Imai, Keiji Kuba, Shuan Rao, Yi Huan, Feng Guo, Bin Guan, Peng Yang, Renu Sarao, Teiji Wada, Howard Leong-Poi, Michael A Crackower, Akiyoshi Fukamizu, Chi-Chung Hui, Lutz Hein, Stefan Uhlig, Arthur S Slutsky, Chengyu Jiang, Josef M Penninger
发表日期
2005/7/7
期刊
Nature
卷号
436
期号
7047
页码范围
112-116
出版商
Nature Publishing Group UK
简介
Acute respiratory distress syndrome (ARDS), the most severe form of acute lung injury, is a devastating clinical syndrome with a high mortality rate (30–60%) (refs ). Predisposing factors for ARDS are diverse, and include sepsis, aspiration, pneumonias and infections with the severe acute respiratory syndrome (SARS) coronavirus,. At present, there are no effective drugs for improving the clinical outcome of ARDS,,. Angiotensin-converting enzyme (ACE) and ACE2 are homologues with different key functions in the renin–angiotensin system,,. ACE cleaves angiotensin I to generate angiotensin II, whereas ACE2 inactivates angiotensin II and is a negative regulator of the system. ACE2 has also recently been identified as a potential SARS virus receptor and is expressed in lungs,. Here we report that ACE2 and the angiotensin II type 2 receptor (AT2) protect mice from severe acute lung injury induced by acid aspiration …
引用总数
2005200620072008200920102011201220132014201520162017201820192020202120222023202415465760464846394856453225292497269234122467
学术搜索中的文章